Sanofi SA
OTC:SNYNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
OTC:SNYNF
|
FR |
|
Sun Peak Metals Corp
XTSX:PEAK
|
CA |
|
K
|
Kyungdong Pharm
KOSDAQ:011040
|
KR |
|
Sparebanken Norge
F:K7I
|
NO |
|
Independent Bank Corp (Michigan)
NASDAQ:IBCP
|
US |
|
F
|
FACB Industries Incorporated Bhd
KLSE:FACBIND
|
MY |
|
C
|
Cahya Mata Sarawak Bhd
KLSE:CMSB
|
MY |
|
M
|
Maxim Global Bhd
KLSE:MAXIM
|
MY |
|
Saga Pure ASA
OSE:SAGA
|
NO |
Wall Street
Price Targets
SNYNF Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for
SNYNF
is 115.7423 USD
with a low forecast of 67.7352 USD and a high forecast of 147.0127 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SNYNF's stock price target?
Price Target
115.7423
USD
According to Wall Street analysts, the average 1-year price target for
SNYNF
is 115.7423 USD
with a low forecast of 67.7352 USD and a high forecast of 147.0127 USD.
What is Sanofi SA's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Sanofi SA's revenue is
2%.
The projected
CAGR
for the next 3 years is
5%.
What is Sanofi SA's Operating Income forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
Sanofi SA's operating income is
2%.
The projected
CAGR
for the next 3 years is
12%.
What is Sanofi SA's Net Income forecast?
Projected CAGR
16%
For the last 14 years the
compound annual growth rate for
Sanofi SA's net income is
2%.
The projected
CAGR
for the next 3 years is
16%.
